XML 61 R42.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Share Capital and Share Premium (Tables)
 12 Months Ended
Dec. 31, 2023
Share Capital and Share Premium [Abstract]  
Schedule of Share Capital Arising on the Share for Share Exchange The share capital arising on the share for share exchange has been presented as share capital in the comparative period.
   Nominal
Value		   Share
Capital		   Share
Premium		   Merger
Reserve		 
   £/$   Shares   $000   $000   $000 
At January 1 2021 per 20-F annual report  £0.03    194,612,289    10,794    111,821    
-
 
Group Reorganization                         
Elimination of share capital in Tiziana Life Sciences Plc  £0.03    (194,612,289)   (10,794)   (111,821)   122,615 
Shares issued pursuant to share for share exchange and consolidation  $0.001    97,306,144    97    
-
    (97)
Elimination of other reserves in Tiziana Life Sciences Plc                       (3,821)
Restated at 1 January 2021  $0.001    97,306,144    97    
-
    118,697 
Shares issued in the period:                         
Conversion of warrants  $0.001    136,854    
-
    156    
-
 
Conversion of Loan  $0.001    1,866,907    2    603    
-
 
Issued in lieu of cash bonus  $0.001    2,962,709    3    14,837    
-
 
At 31 December 2021        102,272,614    102    15,596    118,697 
Shares issued in the period:                         
At 31 December 2022        102,272,614    102    15,596    118,697 
Shares issued in lieu of fees  $.0001    450,000    1    300      
Warrants Exercised  $.0001    337,501    
-
    573      
Issuance of Stock - ATM  $.0001    27,629    
-
    23      
At 31 December 2023        103,087,744    103    16,492    118,697